Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Narrative Review: Efficacy, Safety, and Tolerability of Newer Third-Generation Antiseizure Medications for Focal Epilepsy: A New Benchmark in Treatment Outcomes?
Journal: Neurology and therapy
Published: June 04, 2026
Long-term efficacy of adjunctive cenobamate: Open-label extension of a randomized, placebo-controlled study in a multinational Asian population.
Journal: Epilepsia
Published: May 07, 2026
Wide range of cenobamate doses associated with initial seizure freedom in patients with uncontrolled focal seizures: Post-hoc analysis of a phase 3, multicenter, open-label study.
Journal: Epilepsy & behavior : E&B
Published: July 08, 2025
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures.
Journal: Epilepsia
Published: July 02, 2025
Seizure freedom and reducing the risk of sudden unexpected death in patients with focal epilepsy treated with cenobamate or other antiseizure medications.
Journal: Epilepsia
Published: September 13, 2024
Epilepsy medication management: Addressing common treatment barriers to adopting cenobamate and other new antiseizure medications.
Journal: Epilepsia
Published: September 13, 2024
Last Updated: 09/26/2026